Donald Jones Joins Sentrian Board
Donald Jones, Digital Health Pioneer, Joins Sentrian Board
ALISO VIEJO, CA—January 8, 2015—Sentrian™, the Remote Patient Intelligence™ company aspiring to eliminate all preventable hospitalization, today announced that Donald Jones, a globally recognized leader in digital medicine, has joined the Board of Directors for the company.
Jones is the CEO of Trial Fusion, a company focused on clinical validation and commercializing digital health products and services and is the Chief Digital Officer of the Scripps Translational Science Institute, where he works with the renowned Eric Topol, MD on the convergence of genomics and wireless health. He helped found Scripps Digital Medicine, the world’s first clinical trial center focused on digital health. For 11 he led Wireless Health Global Strategy and Business Development for Qualcomm. He is Founder and Chairman of the Wireless Life Sciences Alliance. Working with the XPRIZE Foundation and Qualcomm’s CEO, Jones conceived the $10 millionQualcomm Tricorder XPRIZE, a global competition for a consumer device which makes medical diagnoses. Jones was a founding board member of the West Wireless Health Institute (now West Health Institute) with Dr. Topol and philanthropists Gary and Mary West, raising over $100 million. CommNexus, the San Diego nonprofit industry group, recognized Jones as 2014 Digital Health Innovator of the Year.
“I am excited by this opportunity to serve on the board of Sentrian, an innovator in the use of analytics to help patients with multiple chronic diseases to stay healthier at home and avoid preventable hospitalization,” said Jones. “Sentrian has an outstanding development team and the expertise in machine learning and other accelerating technologies to help ACOs and Medicare Advantage plans massively scale remote patient monitoring to the population level for the first time. It is nearly impossible to overstate the need for this technology to improve the care and lives of patients with chronic disease, a trillion-dollar problem that affects tens of millions of Americans.”
The Sentrian Remote Patient Intelligence platform addresses the challenge of managing patients with complex chronic disease by bridging the gap between patients and clinicians when the patient is home and away from their care team.
“We are honored that Don has agreed to join Sentrian as a board member,” said Dean Sawyer, Chief Executive Officer of Sentrian. “He is a true visionary in digital health who brings a wealth of relevant technology and operating experience to our Board. His experience at Qualcomm and as a board member of other digital health companies will benefit Sentrian, and I anticipate that his leadership and experience will uniquely contribute to the company’s development during this next chapter of Sentrian’s journey. I look forward to working with him as we continue our efforts in becoming the healthcare industry’s first choice for remote patient intelligence.”
With Jones’s appointment, the Sentrian Board of Directors now has four members including Sawyer; Stuart Frost, a highly successful, serial high-tech entrepreneur who is Managing Partner and CEO of Frost Data Capital; and Kevin Brown, Founding Partner of Reed Elsevier Ventures.
Sentrian™, the first Remote Patient Intelligence™ company, aspires to eliminate all preventable hospitalization by leveraging the revolution in remote biosensors and machine learning to detect patient deterioration early, before it becomes acute. Sentrian’s value proposition to healthcare organizations is to provide a cloud-based remote patient monitoring and analytics platform intended to dramatically reduce preventable hospital admissions, increase the efficiency and effectiveness of care teams and improve quality metrics such as HEDIS and Star ratings. The Sentrian platform is designed to seamlessly integrate with existing healthcare information systems and clinical workflows, facilitating adoption. Find us at www.sentrian.com, on Twitter and LinkedIn.